Shares of Resverlogix Corp. (TSE:RVX – Get Free Report) passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$0.10 and traded as high as C$0.10. Resverlogix shares last traded at C$0.10, with a volume of 27,000 shares trading hands.
Resverlogix Stock Performance
The firm’s 50 day moving average is C$0.10 and its 200 day moving average is C$0.10. The company has a market cap of C$31.70 million, a PE ratio of -5.00 and a beta of 0.35. The company has a debt-to-equity ratio of -83.11, a current ratio of 0.03 and a quick ratio of 0.04.
Resverlogix (TSE:RVX – Get Free Report) last posted its earnings results on Friday, May 15th. The biotechnology company reported C$0.01 earnings per share (EPS) for the quarter. On average, equities analysts anticipate that Resverlogix Corp. will post -0.22 earnings per share for the current year.
About Resverlogix
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Featured Stories
- Five stocks we like better than Resverlogix
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
